Literature DB >> 32012336

3-D printed spectacles: potential, challenges and the future.

Ling Lee1,2, Anthea M Burnett1,2, James G Panos1, Prakash Paudel1, Drew Keys1, Harris M Ansari3, Mitasha Yu1.   

Abstract

Three-dimensional (3-D) printing offers the potential to custom-produce a wide range of manufactured objects and improve manufacturing processes. The additive manufacturing process involves material (resin, metal, ceramics or biological cells) being deposited layer upon layer, which is fused to create a 3-D object. While 3-D printing has been readily available in the aerospace and automotive industries, and is being used increasingly in the medical field, its potential for optometry and ophthalmic optics has rarely been discussed in depth. 3-D printing of spectacles has the potential to provide customised experiences, to cater for those who do not fit standardised frames or for those with irregular prescriptions, and to reduce delivery times and inventory with the opportunity of increasing access to underserved populations. Here we review available 3-D printing technologies, and the current 3-D printed spectacle market, including testing three commercially available spectacle frames to assess compliance with ISO:12870 standards. The article then explores the challenges faced and environmental impact of implementing 3-D printing of spectacles.
© 2020 Optometry Australia.

Entities:  

Keywords:  3-D printing; additive manufacturing; rapid prototyping; spectacles

Mesh:

Year:  2020        PMID: 32012336     DOI: 10.1111/cxo.13042

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  2 in total

Review 1.  3D-Printed Objects for Multipurpose Applications.

Authors:  Nayem Hossain; Mohammad Asaduzzaman Chowdhury; Md Bengir Ahmed Shuvho; Mohammod Abul Kashem; Mohamed Kchaou
Journal:  J Mater Eng Perform       Date:  2021-03-26       Impact factor: 1.819

Review 2.  3D Printing in Eye Care.

Authors:  Ryan D Larochelle; Scott E Mann; Cristos Ifantides
Journal:  Ophthalmol Ther       Date:  2021-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.